Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMAC vs. Hyaluronic Acid in Bilateral Knee Osteoarthritis
NCT03110679Phase 4Completed
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- May 2016
- Primary completion
- Nov 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of autologous bone marrow cell concentrate in osteoarthritis (OA), sponsored by Istituto Ortopedico Rizzoli. Started May 2016; status: completed.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03110679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110679.